AIDS and Viral Research Reagents

AIDS (Acquired Immune Deficiency Syndrome) is the final stage of a disease caused by the Human Immunodeficiency Virus (HIV). HIV/AIDS causes severe damage to the immune system, and a variety of treatments are able to keep symptoms at bay and improve the quality of life. Antiretroviral drugs can stop the virus from multiplying, prevent the progress of the disease, improve T-cell counts, and help the immune system. Viruses are responsible for other infectious diseases like the common cold, influenza, rabies, and measles. Viruses known as oncoviruses contribute to certain forms of cancer. While vaccination provides one treatment option to prevent some viral diseases, another option is the development of antiviral drugs . The first such drug was interferon, produced by immune cells to stimulate other aspects of the immune system. Sigma-Aldrich offers antiviral compounds and other products for research on HIV, AIDS, and other viral diseases.

Product #

Description

Add to Cart

SML1010 L-742001 hydrochloride ≥98% (HPLC)
SML0089 Abacavir sulfate ≥98% (HPLC)
A4669 Acycloguanosine ≥99% (HPLC), powder
SML0240 Adefovir ≥98% (HPLC)
SML0685 Amprenavir ≥98% (HPLC)
SML0250 anti-3-OS HS peptide trifluoroacetate salt ≥98% (HPLC)
SML0860 Arbidol hydrochloride ≥98% (HPLC)
A6486 AS-136A ≥98% (HPLC)
SML1796 Atazanavir ≥98% (HPLC)
A2169 3′-Azido-3′-deoxythymidine ≥98% (HPLC)
BM0022 BMS-433771 bis-hydrochloride monohydrate ≥98% (HPLC)
B9647 (E)-5-(2-Bromovinyl)-2′-deoxyuridine
SML1473 Chlorcyclizine ≥98% (HPLC)
C5874 Cidofovir hydrate ≥98% (HPLC)
SML0937 Darunavir ≥98% (HPLC)
D8296 3-Deazaadenosine
PZ0180 Delavirdine mesylate ≥98% (HPLC)
D1413 2′,3′-Didehydro-3′-deoxythymidine ≥98% (TLC)
D5782 2′,3′-Dideoxycytidine ≥98% (HPLC)
D0162 2′,3′-Dideoxyinosine ≥98% (HPLC)
SML0536 Efavirenz ≥98% (HPLC)
SML0934 Enfuvirtide acetate salt ≥95% (HPLC)
SML1103 Entecavir ≥98% (HPLC)
SML1929 Equisetin (Fusarium equiseti), ≥97% (HPLC) New
F7932 Famciclovir ≥98% (HPLC)
SML0632 Fialuridine ≥98% (HPLC)
PZ0030 Filibuvir ≥98% (HPLC)
G2536 Ganciclovir ≥99% (HPLC), powder
SML1824 GSK983 ≥98% (HPLC)
SML1825 GSK984 ≥98% (HPLC)
H8909 HBcAg core human ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H7410 HBV core δ antigen (HBcAg) human ~1 mg protein/mL, 95% (SDS-PAGE), recombinant, expressed in E. coli, clone HBV 320
H7035 Hepatitis C virus core antigen−Biotin ~1 mg/mL, >95% (SDS-PAGE), recombinant, expressed in E. coli
H7160 Hepatitis C virus core antigen−Fluorescein ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H9159 Hepatitis C virus core antigen−Rhodamine ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H9284 Hepatitis C virus NS3 antigen 22kDa 0.5-1.4 mg/mL, ≥90% (SDS-PAGE), recombinant, expressed in E. coli
H9534 Hepatitis C virus NS4 antigen ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H7285 Hepatitis C virus NS4 antigen−Biotin ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H9659 Hepatitis C virus NS4 antigen−Fluorescein ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H9784 Hepatitis C virus NS4 antigen−Rhodamine ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli, solution
H9034 Hepatitis C virus core antigen ~1 mg/mL, ≥95% (SDS-PAGE), recombinant, expressed in E. coli
H6387 His-Cys-Lys-Phe-Trp-Trp ≥95% (HPLC)
H9909 HIV-1 env antigen ≥95% (SDS-PAGE), recombinant, expressed in E. coli, Galactosidase-tagged
H4285 HIV-2 env antigen ≥95% (SDS-PAGE), recombinant, expressed in E. coli, Galactosidase-tagged
H0160 HIV-1 gag ≥95% (SDS-PAGE), recombinant, expressed in E. coli, Galactosidase-tagged
SML1562 HIV inhibitor 18A ≥98% (HPLC)
H0285 HIV-1 nef >95% (SDS-PAGE), recombinant, expressed in E. coli, Galactosidase-tagged
H5785 HIV Protease Substrate VIII >96% (HPLC)
H5410 HIV Protease Substrate V >98% (HPLC)
H0292 HIV-1 Tat Protein (47-57)
SML0251 anti-HS peptide trifluoroacetate salt ≥98% (HPLC)
SML1199 ID45 ≥98% (HPLC)
I9759 Ile-Pro-Ile ≥97% (HPLC)
SML0189 Indinavir sulfate salt hydrate ≥98% (HPLC)
SML1871 KIN1400 ≥98% (HPLC)
SML1866 KIN1408 ≥98% (HPLC)
L1295 Lamivudine ≥98% (HPLC), powder
SML1222 Lopinavir ≥98% (HPLC)
L6525 Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle amide ≥97% (HPLC)
M9812 α-MAPI ≥95%, solid
PZ0002 Maraviroc ≥98% (HPLC)
M4949 2’-C-Methylcytidine ≥95% (HPLC), powder
SML0713 2′-C-Methylguanosine ≥98% (HPLC)
SML1145 ML303 ≥98% (HPLC)
D6819 N2-[[5-(Diphenylmethyl)-2-furanyl]carbonyl]-L-Arginine hydrate ≥98% (HPLC), powder
SML0812 NBD-556 ≥98% (HPLC)
PZ0013 Nelfinavir mesylate hydrate ≥98% (HPLC)
SML0097 Nevirapine
SML0426 NPD4456 ≥98% (HPLC)
SML0973 NSC 37249 dihydrochloride ≥98% (HPLC)
N8164 NSC727447 ≥98% (HPLC)
N2790 Nucleozin ≥98% (HPLC), powder
SML1383 OG-L002 hydrochloride ≥98% (HPLC)
SML1606 Oseltamivir phosphate ≥98% (HPLC)
SML0667 PF-429242 dihydrochloride ≥98% (HPLC)
SML0835 PF74 ≥98% (HPLC)
SML0461 PH-002 ≥98% (HPLC)
SML1592 Pimprinine ≥98% (HPLC)
SML1818 Pirodavir ≥98% (HPLC)
A8111 Plasminogen activator inhibitor 1 (PAI-1) human recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
SML0307 Pleconaril ≥98% (HPLC)
SML0561 REDD1 inducer ≥98% (HPLC)
R9644 Ribavirin antiviral
SML1695 RSV604 ≥98% (HPLC)
PZ0315 Rupintrivir ≥98% (HPLC)
SML0214 SAMT-247 ≥98% (HPLC)
S5895 Sangivamycin hydrate from Streptomyces rimosus
S8451 Saquinavir mesylate ≥98% (HPLC), powder
S3451 SID 852843 ≥98% (HPLC)
SRP3155 SLIT-2-N human recombinant, expressed in HEK 293 cells, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
SML1088 SRPIN340 ≥98% (HPLC)
SML0293 Telbivudine ≥98% (HPLC)
SML1795 Tenofovir ≥98% (HPLC)
SML1794 Tenofovir disoproxil fumarate ≥98% (HPLC)
T7765 Tunicamycin from Streptomyces sp.
V9889 Valacyclovir hydrochloride hydrate ≥98% (HPLC), solid
SML0191 Valganciclovir hydrochloride hydrate ≥98% (HPLC)
SML0492 Zanamivir ≥98% (HPLC)